A Randomized, Controlled, Multi-center Collaborative Study to Evaluate the Efficacy of Magnesium Isoglycyrrhizinate Injection in the Prevention of Antineoplastic Chemotherapy Related Acute Liver Injury
Total subjects: 2040, experimental group of 1360 patients, control group of 680 patients.
According to the study subjects receiving antineoplastic chemotherapy, subjects are
stratified randomize.
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
The incidence of liver injury
anyone of ALT、AST、ALP、TBIL、DBIL、γ-GT>ULN
0-15 days
No
Qin Shukui, MD
Principal Investigator
The 81st hospital of PLA
China: Food and Drug Administration
MAGIC-301
NCT01802996
March 2013
August 2014
Name | Location |
---|